Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.
<a href="https://news.google.com/rss/articles/CBMipgFBVV95cUxNTU1aM1Fpc1lFLThGeGdDd08xendtWlJRS2dZSDROd3k3TFRMVnl4amgzeUhQWjBETWtaNXotcUhwOTRJYmY1MkRPV3NNVk9QdkRGdWJUUEdrdXV0eWc0M0MtZC1oMUZpYUFhTEN5bmxYTnRablRRdHhxbzI2UTRHbEhSVk5vMThjRHI1Q2htV0RRS2FnNXdjZ1BxZU1SMlVPN3FKMWxn?oc=5" target="_blank">2026 Orphan Drugs Report: A safe(r) passage amid stormy waters?</a>&nbsp;&nbsp;<font color="#6f6f6f">BioPharma Dive</font>
"You want to play for Morocco?": Getafe defender provokes Yamal with shocking words
Acclaimed Author Denies Using A.I. but Admits Plagiarism
OpenAI engineer arrested in bugging of executive conference room
The Myth of St. Francis
Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxOVHJNQXNhOEx3dzJmYjAwakNmR0Jqa3ZDNnZVTDVlSVlMZ1ZsTTY5Q1BRMm4zY25LLUVLcncyNEJEejNHZ3BPR2VTMndOSUVqdzR4T2dtYXVPN0RnX0NxT3NidHpRT0ZrbEpzSTdKZDRQN3hwdHlfSldRUXN4QmJrckR3M2ptR3FrQmJEOEN3?oc=5" target="_blank">CLN-049 Gains FDA Orphan Drug Designation in R/R AML</a>&nbsp;&nbsp;<font color="#6f6f6f">Targeted Oncology</font>
<a href="https://news.google.com/rss/articles/CBMiiwFBVV95cUxQajNmdDNWTzYzY3k4YmVVRGM3eVR1NHNXQ014NmM3R0F0cXRBbTR0RmFlNGRhSDdKd19saXFfbWtrSVhvTWZQTDJWQzhUMFlMc3AzT3hvVnY2cHllVXEyb1dJcWxrMGRkMHpJeDMtNXJOOXMwTzNnN1FKbENTc2JlVTBINDlsWk4zSlNV?oc=5" target="_blank">Stem cell therapy for ALS still available to patients in Asian nation</a>&nbsp;&nbsp;<font color="#6f6f6f">ALS News Today</font>
<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxOVS11VnBmSWk2VjlHZmlVbk5YYWdxZVN5cTRmYUhrN2FCS0t4aFczTHI3NE5tWElDZ29Pc2lCek43UFdnOFRySDl3OHlIdjd6VEVVVHRuQnl1VmVBSGRoTHd4aEVVUElkdFlKTGtSR1JSZzBqaG0zM2VHS0sxY0pxMzhkSkliaG4ybE1PVFZsTXdsNmxodWhMSHVHbk1aMEs5Zl9WWlRLYw?oc=5" target="_blank">Prescription Drug Affordability: Examining Select Price Drivers</a>&nbsp;&nbsp;<font color="#6f6f6f">Bipartisan Policy Center</font>
<a href="https://news.google.com/rss/articles/CBMioAFBVV95cUxNNTZ0Z3d6WFlrRjVNVF9VdndVQ19Eam0wM1JDNEVRcnBxUTJTWURCRk9MLVVCY1ZsZGgxSC1jZnRDQ09IdUtJcTZSVjRDVzAzaUFnOWhTaXJicHFVSTh2UTRlN3ItRWR1NVBHaFEtSTZUejJ0Q2Q5anhDNnBHS1JvLXE1QjZEOW8zYkNSYTRKMUNKQnFHNGV2YlRHSUtETHZY?oc=5" target="_blank">FDA Fast Track Designation for Oncology Drugs in April 2026</a>&nbsp;&nbsp;<font color="#6f6f6f">Oncology News Central</font>
<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxNWVVvMS0ta21zcXhSckFsSWpRRUY3TEdKa0lBa3BBa3o4LVhpdkZGdDFDVGhnUlItOXUxRktRcHF1Z1lNVnV4Tmg0dDZCMS04dy1ja2RWaVRxQ3d3b05GdVRPSmlybEp0N2FUNVpzQkRvbmRHTHdNUURCZUNrMXR3ZHVwc2tELUZDd1J4Y0JB?oc=5" target="_blank">Societal participation in the development of orphan drugs: a systematic review</a>&nbsp;&nbsp;<font color="#6f6f6f">Frontiers</font>
<a href="https://news.google.com/rss/articles/CBMiekFVX3lxTE1jbXlVTVp0V19vLTBteG5DY3EyNGtYcDlTeUNEQkZzRm5EdlhLbzBOVWZ0OHZlanU3WUt5LUZvQWNPaHBCX2UzNUwyQ2ZlUGdhUFhFMkZFVXhRU2dlWFlfNVlZYjZZRkNpV19Ud3lvM2lRbjZOWWdza2hR?oc=5" target="_blank">India gets US speciality-drug tariff relief</a>&nbsp;&nbsp;<font color="#6f6f6f">Telangana Today</font>
<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxOb09taTJ1RVJfZ2RZNnMtU2JsN2VkUTVKOFBhbkN0Ujg1TmRSel9hM2xqMTVkZlFVemRWWFF5RnBnUURRZU5sVTBfX2xjVHFBUnNkSzBRZHlkd1ExSkFZOXEtSG9nS2NiN2RPcEh6MTdoU01KQlduRVpUU0tIQ0dBMnR5RnZJcktSOTlfWmNraExYWTZScFVvbHJzWXpFVXhGNUE?oc=5" target="_blank">IRA Leaves Orphan Drugs Stranded Even as Regulators Promise Progress</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMidEFVX3lxTE9XcFpFSUpPRWdXaXZtdlhvektMS2xWcl9BdWZKaDNjdENCLTVZZE5UWWowYlFRSUhTbXZJcVlBM2hremNxWmJyRmZyRGxHNnRwTlg3Y1hOSjV6b1Q4dUhmTHVEc0FLZkR3QXoydDFIamZqSmxN?oc=5" target="_blank">Is pharma’s interest in orphan drugs waning?</a>&nbsp;&nbsp;<font color="#6f6f6f">pharmaphorum</font>
<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOVm04bHgyTW5BS1k2UlBhOFh0ZnVQYmM0Q2g2MDZTUVNacTM4ZExFM0pWWHhfNzc4emcxUHFkd0kxMnVyc094SlFVdTZaQnlTMGpGLW51bFdkYUZuMGQwT1FxZ01jV1ZablRTa2NZeUluZXVQdHB0Q1hwcGFZV1FWdTh5Ty1mOGpUMjFSSlgyUHBIZWVFcHl5VDVR?oc=5" target="_blank">Closing the Orphan Drug Act Loophole</a>&nbsp;&nbsp;<font color="#6f6f6f">Mintz</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQZng4RUUwQWhIeWNteDFRM0lKZy03dVkzNGxlVzJ5c0h1Sk5VSWZYS1pkaFNxeXpPcmxuNDE2eHd1MHF3MmpvQXk4OXFGYjhPZjdLU09kRmxNMnZoc1lMVWp6TVZ6NE9VSFh4MmI5eXVCWFdWMUtYSUtOTHVjaXVmYVptaDZwWndINTNVaG5yTUFkNWV2QUtVOG1VTQ?oc=5" target="_blank">Incentivizing rare disease R&D is getting tougher, but revamped policies could turn the tide</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharma Voice</font>
<a href="https://news.google.com/rss/articles/CBMilgFBVV95cUxNcWdGV2FFUWJqbWlYbk5Yc2p6ejdCYUdIX1NyY3BXUFBsT0ZlTTlINWdNbjU1MUllX3FSNnh0SVprbFN6d05rN1d6VTVCZUdlcG85bWR5UmlIUFpvNE82MkFIZXNZV2hGZTNPS2ZsMm5EaXNHNlROVklzZUxaNnZzRnZJUy1kdm4xeG1MaUc0bi1EM2s0blE?oc=5" target="_blank">SAR446523 Receives FDA Orphan Drug Designation for R/R Myeloma</a>&nbsp;&nbsp;<font color="#6f6f6f">OncLive</font>
<a href="https://news.google.com/rss/articles/CBMi4gFBVV95cUxQOXkxUnBKUE1tUnpxNDRoSEpyamE5Y3A2UmFvXzVCMDduUXdka2xRZ251SDdCSElaa2diNTVHMy1wbXJYMU54SjR5M25mbEw1UTNxR0EzeGU4OWc2M2V1WEZieVUzT2hyR3JtYTU4UmJySzFpV21ad2tMVWtQcU50Yy1UdndfWDhGU21qTFJ6b0VsdUtqVHFlTkVpYmxURmJrV2t4bk94blBkZWZyS0xyM2JkNEh5QlVsdEdrM1pKeEdsT2RTVF91NlAxa3VrbHFEcHBPMHhyc2ExTVAtRExZRkpR?oc=5" target="_blank">Parliamentarian reverses course, allows orphan drug provision in megabill</a>&nbsp;&nbsp;<font color="#6f6f6f">Politico</font>
<a href="https://news.google.com/rss/articles/CBMihAFBVV95cUxPQVkxQjFNNnhVS25LdHVuUUxBS2tXemI0cG16ZC1CRks4STdYOEZvTzIyRmcyY1czSkxnQm9MNGxSTlNiX2FMRU9iQVo4cU1WMmxhSjBOYTNMajBuMGhVT1Z2d0NWTm9NMlpSbEh4VnlxcWRfZmQyMVZZS0FnVzJLbElZeGQ?oc=5" target="_blank">Orphan Drugs Market Size, Share, Growth Report 2026-2033</a>&nbsp;&nbsp;<font color="#6f6f6f">Grand View Research</font>
<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxOZ25XdGJzN0FzX2V0bkNHN3lhZjBQYjBLMUFLclZlT0xMRWw4UDdrVHNMd1k5ak5SeWRRMzZSdl9mM2o4OWdicGVfXzlpV3BIRG90OXBXMHF0Y0hjdXJSTmFMbDNwbC1qT1M5NVRTVHhSRjZVel9nN0xCYjdFQWRIMVlZZF9PV1RjRFhmVWhZRmRONm02NGh5SENFbTFDM1JTZDhpdkFla05pV05uX3F1X2NzOGpBd205YXlYOTQ0OHdpVUFPRFM4ci1NRQ?oc=5" target="_blank">SAR446523 Granted Orphan Drug Designation for Patients With Relapsed, Refractory Multiple Myeloma</a>&nbsp;&nbsp;<font color="#6f6f6f">Pharmacy Times</font>
<a href="https://news.google.com/rss/articles/CBMiUkFVX3lxTE1DNlVfa01kNWU2R3Q1Z3lUeENvcEZ2M3VPa1ZHNEpxd1ZLN1VSZ0tsT0laS0NaYTBCV3hIOW8zQUVfN1l3QmR3STNiV2dnbDN3MEE?oc=5" target="_blank">Pharma Reaps Billions Off Orphan Drug Designations, Says New Report By Dutch Investigative Group</a>&nbsp;&nbsp;<font color="#6f6f6f">Health Policy Watch</font>
<a href="https://news.google.com/rss/articles/CBMitgFBVV95cUxQZm0yYVphS3hEYUJSd3JnbGJCWWFhbG9TV3NYTmZ6Nl9KcjJCNWlGZG01S2x0MFV5T0E1YXEwVGdFaTBNM0VqMTUwNnFGTXV3cUR3YVdlTkZPLWhZaFRuQzl6SXROUnNxaTRtZlpETDlLNzJiYkhKZjhNbmxuT3VpVzJsVzNxT0F6UF9STk1sZl9XRV8yZTVjcFJzM1pzTWliTmIydkMwajNpZHFXcHBkajgxN3FPUQ?oc=5" target="_blank">Incentives For Drug R&D: A Survey Of Biotech Venture Capitalists’ Perspectives</a>&nbsp;&nbsp;<font color="#6f6f6f">Health Affairs</font>
<a href="https://news.google.com/rss/articles/CBMiwwFBVV95cUxQWEhzWDBSZzk0a3pvNDdRaGczQzlYY2NpQ3NLcTRLbVo0eG1WUHJmMUxXa3g4aDNaLW1EaUR6RU5DbEs2NUp4VVF2djR0a3Bxc3JfX09zRmxrSV9sNGFQTzdhY193LTRKcTI4eUdPTHlieHZnY2Jsb3owZ3lQWVI3bVU0YWV5SGdSS3ZzMHdDLUduSXBaRHpEei1OeGJZemVXR3F0Sk5qUkxtc3QwQzd1c0xUcWxtdmp4UnMtYUlYS3FyV3c?oc=5" target="_blank">The Inflation Reduction Act Is Negotiating the United States Out of Drug Innovation | Reports & Briefings | Feb 25, 2025</a>&nbsp;&nbsp;<font color="#6f6f6f">Information Technology and Innovation Foundation</font>
<a href="https://news.google.com/rss/articles/CBMimwFBVV95cUxQamRlbmpiMXhMWWZmejBfVkdQYmtyYThRQXpuNlIxSjdkYVJxMWRETTZLWDBOYVJxN0RFZUIwdG1qU1FoTE1JVW9hYUpUVmZDOXd5MXNzZHRtNmhBeXNwV3hGUEt4NjJ2Qzlqem1IZGQxcXBpeUJ5c0dTVzJXT2dhX1JSRnZnSHpqMGstZWgxUWZHc2xJeENwY2JXWQ?oc=5" target="_blank">Patient Death Prompts Hold on Arcellx’s CART-ddBCMA for R/R Multiple Myeloma</a>&nbsp;&nbsp;<font color="#6f6f6f">CGTLive®</font>
<a href="https://news.google.com/rss/articles/CBMiugFBVV95cUxNMEtXM2FDdjVCRVR4UXZTOHY2cVozU2JMRzJsZzNSaWc2WXZkV2ZYcUltYU1Bbkxld3ljSmc5dEp4VzIwMU1yNDJjZnlqc3lOdVZTMVBQaDZneFpQMmg1clRYdmw4UnpiWUxMdW8xZ0VuMDhHX0ZENkFGSlpGaGk3Vl9ndjFtXzNPUUFlMUFxMHJNZHIyNHVubWgxN0ZXU1drcE0tVlBUZkZYNlpZU0l3RTI5ZE81dmt0MXc?oc=5" target="_blank">Facing a Dearth of Big Pharma Interest, Rare Disease Players Get Creative to Fund R&D</a>&nbsp;&nbsp;<font color="#6f6f6f">BioSpace</font>
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxOaml3RUp2WkRkdUlBSzBsMUZIbjV5MGhMQm5rWWVxby1uVkc2ZU5MTmFrODJiaWR0UFdOQzRkbzlJWFI5bTRvN2pMcnJjcWM1QkdOcElrNVJmTmVTTDZmUlBHNEo4V3h1SkR1Uk5HSFkyRVhXS0ZGTFJuNDZoY0RNWGdkbzNtdXlwZ25ER2RwQndkaHNiYnNOREk1N1NEQVFMbDVTMGh4WGtzQWJSS2g3MGhkeXMwMEE?oc=5" target="_blank">Pfizer CEO says R&D is the 'lifeblood that fuels us' as spending revs up post-COVID</a>&nbsp;&nbsp;<font color="#6f6f6f">Fierce Biotech</font>
<a href="https://news.google.com/rss/articles/CBMizwFBVV95cUxPcHRnSHFGNlA3U2h4cFRfNU1CQUhUWHlQNXRVM1lUN3I2TGhmbUdOYmtrZ25jM0lPeGs5ZUxkcnNoVkV3S2JlbmpsZVZkZGRCY3N4WnZtWW5wRm12M3phR09nTG5OdnBuaDd3cERyQzljbzUwR0dfMms2R1FOUHJCTmJqbmtBWDRqNnY0QU8yRFlYbUNXb19qblUyS29rMjJfTzlmWEo4am5aZk1QYzZXWERCejlGc1lTaGtIU1FLdGFXVzB3WDNxSzNpQk1pR2c?oc=5" target="_blank">'It can be really bad': Vascular Ehlers-Danlos syndrome treatment options remain limited</a>&nbsp;&nbsp;<font color="#6f6f6f">Healio</font>
<a href="https://news.google.com/rss/articles/CBMirwFBVV95cUxPYVNfWVM3Q1NwN291RGtGU2dNWVU4MzBleWcwMVo4eGFIaVZxSmhMUjh2Y3ZoVzJqcDZWd1F0VGwyOGM5ck55TzExZ3JnUGZCN3FyU0RnMUJSVjJ5amJMZ3htNkt3RXhBdXRWLVZ6c3ZpcThjaks1QmcxSGJsMGlVTzUzUUV3NUtuQ3EtOTN0WnZTRlJ5ZU5lZ2hzN0dlUWZOOEJURXJhZVlmSEtYbHgw?oc=5" target="_blank">50 cancer, rare disease drugs to get cheaper</a>&nbsp;&nbsp;<font color="#6f6f6f">The Times of India</font>